1.WELL Health Technologies Corp.
WELL.TO (TSX)
WELL Health Technologies Corp. stands out as a leading healthcare technology and clinic operator in Canada, actively traded on the TSX. With a recent 1-year return of 2.18% and a challenging 5-year performance at -40.54%, analysts from Scotiabank rate it as a "Perform," suggesting a cautious outlook amidst its recognition in the healthcare sector.
Pros:
- Active in the growing healthcare technology sector
- Strong historical 10-year return
Cons:
- Negative 5-year return
- Market volatility risk
2.BioSyent Inc.
RX.V (TSXV)
BioSyent Inc. stands out as a top-rated Canadian healthcare and pharma company, recognized by Investing News Network as one of the best in 2026. With a robust 1.51% dividend yield and impressive returns of 16.74% over the past year and 77.71% over five years, it offers attractive opportunities for investors seeking financial stability and growth. Analysts have given it an A- rating, underscoring its position in the market as a financially healthy option for those focused on reliable income.
Pros:
- Consistent quarterly dividends
- Strong historical growth
Cons:
- Recent short-term trading dip
- Market cap under $200M
3.Knight Therapeutics Inc.
GUD.TO (TSX)
Knight Therapeutics Inc. stands out as a top Canadian specialty pharmaceutical company, recognized among the leading stocks in the sector for 2026. With impressive returns of 40.69% over the past year and 54.55% over five years, it offers a compelling opportunity for investors. Analysts, including Raymond James, maintain an "Outperform" rating, reflecting confidence in its robust growth strategy and market positioning.
Pros:
- Strong recent performance
- Diverse pharmaceutical product offerings
Cons:
- Market volatility risk
- Lower 10-year return
4.Diversified Royalty Corp.
DIV.TO (TSX)
Diversified Royalty Corp. stands out as a healthcare-related income stock listed on the TSX, appealing to investors seeking reliable dividends. It boasts a robust dividend yield of 6.45% and has delivered impressive returns of 64.16% over the past year and 90.87% over five years. With strong analyst ratings, this stock emphasizes financial health and consistent payouts, making it an attractive option for income-focused investors.
Pros:
- High dividend yield
- Strong recent performance
Cons:
- Market cap under $1B
- Potential dependency on specific sectors
5.Medexus Pharmaceuticals Inc.
MDP.TO (TSX)
Medexus Pharmaceuticals Inc., a leading player in the Canadian pharmaceutical sector, has gained recognition as one of the best-performing Canadian pharma stocks for 2026. Despite a significant 5-year return decline of 45.60%, the company recently delivered a 1-year return of 35.62%. Analysts from Canaccord Genuity have issued a cautious "Hold" rating, indicating a wait-and-see approach amidst the stock's volatile performance.
Pros:
- Strong recent momentum
- Broad analyst optimism
Cons:
- Negative 5-year return
- Market volatility risk
Final Words
As you consider the best healthcare stocks in Canada this June 2026, remember to evaluate your investment options carefully. Take time to compare the potential of each stock and conduct your own research to make informed decisions that align with your financial goals.
Frequently Asked Questions
WELL Health Technologies Corp. is a Canada-listed healthcare technology and clinic operator actively traded on the TSX under the ticker symbol WELL.TO. The company offers a range of digital health services including primary care, specialty care, and telehealth.
WELL Health Technologies Corp. has shown a 3-month return of 0.24%, a 6-month return of 8.51%, and a year-to-date return of 5.51%. However, over the past year, the stock has seen a return of 2.18%.
Over the long term, WELL Health Technologies Corp. has demonstrated significant growth with a 10-year return of 3408.33%. However, it's important to note the stock has faced challenges, with a 3-year return of -10.99% and a 5-year return of -40.54%.
Investors should consider factors such as market trends in the healthcare sector, the company's financial stability, and potential growth opportunities. It's also advisable to look at the stock's performance metrics and analyst ratings to make informed decisions.
WELL Health Technologies Corp. has a market capitalization of approximately $1.08 billion CAD. This figure can be an important indicator of the company's size and market presence within the healthcare sector.
Investing in healthcare stocks can involve risks such as regulatory changes, market volatility, and competition within the sector. Investors should conduct thorough research and consider their risk tolerance before making investment decisions.
